We understand the importance of Cost Effectiveness and timely execution of Projects for any pharmaceutical Organization. We strive to excel in every stage of Product development and deliver significant value to our clients.
Our Partners have dedicated team for formulation development of INDs, NDAs and ANDAs from preclinical to commercialization. We also do offer Ready dossier for various markets.
Mindswift Pharmaceuticals provides comprehensive Pharmaceutical Research and Development services through our partners for various dosage forms.
Oral solid dosage formsWe provide integrated clinical offerings in Early Phase (Phase I/IIA), Late Phase (Phase II-IV), and Bioequivalence (BA/BE) Studies.
At Mindswift Pharmaceuticals , our goal is for excellent quality Clinical research services. Our Partners have rich experience, vast knowledge and advanced technologies to conduct studies. With strong local know-how and regulatory experiences we can suggest the right partner for conducting Clinical trial in India.
Clinical development team combines scientific expertise, open communication and trust to build lasting relationships with our clients by offering collaborative solutions throughout the entire clinical development process to provide you with high enrolment rates, best timelines, high quality data, and a competitive price.
We understand the strategic importance of India as an ideal choice for Bioequivalence study, as the country offers multiethnic population and availability of healthy volunteers for the study.
Financially, the overall value on a project can be significantly reduced by about 20-50% with study been conducted in India.
In the pharmaceutical industry, “technology transfer” refers to the processes that are needed for successful progression of stages ranging from drug discovery, product development, clinical trials to full-scale commercialization or it is the transfer between development and commercialization at different sites within or outside an organization.
Mindswift Pharmaceuticals can offer ready Technology of Generic Product for Local manufacturing which shall help to reduce the R&D cost and also significantly reduces the timeline for launch of products in market.